BEAM: Beam Therapeutics Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,913.94
Enterprise Value ($M) 1,478.04
Book Value ($M) 981.33
Book Value / Share 12.46
Price / Book 1.95
NCAV ($M) 732.66
NCAV / Share 9.31
Price / NCAV 2.61

Profitability (mra)
Return on Invested Capital (ROIC) -0.11
Return on Assets (ROA) -0.10
Return on Equity (ROE) -0.17

Liquidity (mrq)
Quick Ratio 5.89
Current Ratio 5.89

Balance Sheet (mrq) ($M)
Current Assets 1,211.04
Assets 1,459.71
Liabilities 478.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 377.71
Operating Income -176.49
Net Income -132.53
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -149.19
Cash from Investing 71.84
Cash from Financing 276.45

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A ARCH Venture Fund IX, L.P. 6.80 -6.26
02-13 13G/A Vanguard Group Inc 8.79 14.21
02-12 13G/A Farallon Capital Partners, L.P. 5.00 -0.19
02-09 13G/A Fmr Llc 10.98 15.25
02-06 13G/A Temasek Holdings (Private) Ltd 3.80 -15.60
01-29 13G/A ARK Investment Management LLC 11.53 14.38
01-25 13G/A BlackRock Inc. 8.20 27.18
01-24 13G State Street Corp 5.66

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 313,822 1,601,730 19.59
2024-04-18 355,071 575,805 61.67
2024-04-17 155,304 1,443,197 10.76
2024-04-16 196,663 1,676,103 11.73
2024-04-15 254,918 2,234,343 11.41

(click for more detail)

Similar Companies
BBIO – BridgeBio Pharma, Inc. BCRX – BioCryst Pharmaceuticals, Inc.
BDTX – Black Diamond Therapeutics, Inc. BIIB – Biogen Inc.
BLUE – bluebird bio, Inc.


Financial data and stock pages provided by
Fintel.io